Pediatric Cancer
5 protocols meet the specified criteria.
-
BMMRD
bMMRD - Biallelic Mismatch Repair Deficiency Syndrome Biobank -
COG-ANBL00B1
Neuroblastoma Biology Studies -
COG-ANBL1232
COG-ANBL1232 - Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma - A Group Wide Historically Controlled Phase III Study -
COG-APEC14B1
APEC14B1 - Project: EveryChild - A Registry, Eligibility Screening, Biology and Outcome Study. -
COG-ARST1431
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)